Kobayashi M - Search Results

1

ONO-4007, a new synthetic lipid A derivative, induces differentiation of rat myelomonocytic leukemia cells in vitro and in vivo.

Kobayashi M, Nagayasu H, Hamada J, Takeichi N, Hosokawa M. Kobayashi M, et al. Exp Hematol. 1994 May;22(5):454-9. Exp Hematol. 1994. PMID: 8174676

2

Involvement of oxygen radicals in the differentiation of rat myelomonocytic leukemia cells in vitro and in vivo.

Kobayashi M, Nishihara J, Fujii Y, Maeda H, Hosokawa M, Takeichi N. Kobayashi M, et al. Leuk Res. 1994 Mar;18(3):199-203. doi: 10.1016/0145-2126(94)90115-5. Leuk Res. 1994. PMID: 8139287

3

Defective calcium influx in rat myelomonocytic leukemia cells which are resistant to differentiation-inducing effects of lipid A.

Shinobu N, Kobayashi M, Wang J, Li YQ, Imai K, Matsuno K, Hosokawa M. Shinobu N, et al. Among authors: kobayashi m. Exp Cell Res. 1996 Jul 10;226(1):191-6. doi: 10.1006/excr.1996.0218. Exp Cell Res. 1996. PMID: 8660955

4

The mechanism of locally enhanced production of tumor necrosis factor-alpha in tumor tissues by the administration of a new synthetic lipid A analog, ONO-4007, in hepatoma-bearing rats.

Kuramitsu Y, Ohiro Y, Matsushita K, Obara M, Kobayashi M, Hosokawa M. Kuramitsu Y, et al. Among authors: kobayashi m. Anticancer Drugs. 1997 Oct;8(9):886-93. doi: 10.1097/00001813-199710000-00010. Anticancer Drugs. 1997. PMID: 9402316

5

Therapeutic effects of a new synthetic lipid A analog, ONO-4007, on rat hepatoma KDH-8 depend on tumor necrosis factor-sensitivity of the tumor cells.

Kuramitsu Y, Matsushita K, Ohiro Y, Obara M, Kobayashi M, Hosokawa M. Kuramitsu Y, et al. Among authors: kobayashi m. Anticancer Drugs. 1997 Oct;8(9):898-901. doi: 10.1097/00001813-199710000-00012. Anticancer Drugs. 1997. PMID: 9402318

6

ONO-4007 induces specific anti-tumor immunity mediated by tumor necrosis factor-alpha.

Matsushita K, Kobayashi M, Totsuka Y, Hosokawa M. Matsushita K, et al. Among authors: kobayashi m. Anticancer Drugs. 1998 Mar;9(3):273-82. doi: 10.1097/00001813-199803000-00010. Anticancer Drugs. 1998. PMID: 9625438

7

Establishment of a retrodifferentiated cell line from a single differentiated rat myelomonocytic leukemia cell: possible roles of retrodifferentiation in relapses of leukemia after differentiation-inducing therapy.

Kobayashi M, Nagayasu H, Kuramitu Y, Shinobu N, Takeichi N, Hosokawa M. Kobayashi M, et al. Leuk Res. 1994 Dec;18(12):929-33. doi: 10.1016/0145-2126(94)90104-x. Leuk Res. 1994. PMID: 7527883

8

A new synthetic lipid A analog, ONO-4007, stimulates the production of tumor necrosis factor-alpha in tumor tissues, resulting in the rejection of transplanted rat hepatoma cells.

Kuramitsu Y, Nishibe M, Ohiro Y, Matsushita K, Yuan L, Obara M, Kobayashi M, Hosokawa M. Kuramitsu Y, et al. Among authors: kobayashi m. Anticancer Drugs. 1997 Jun;8(5):500-8. doi: 10.1097/00001813-199706000-00013. Anticancer Drugs. 1997. PMID: 9215614

9

A possible role of 92 kDa type IV collagenase in the extramedullary tumor formation in leukemia.

Kobayashi M, Hamada J, Li YQ, Shinobu N, Imamura M, Okada F, Takeichi N, Hosokawa M. Kobayashi M, et al. Jpn J Cancer Res. 1995 Mar;86(3):298-303. doi: 10.1111/j.1349-7006.1995.tb03054.x. Jpn J Cancer Res. 1995. PMID: 7744700 Free PMC article.

10

Restoration of interleukin-2 production in tumor-bearing rats through reducing tumor-derived transforming growth factor beta by treatment with bleomycin.

Yuan L, Kuramitsu Y, Li Y, Kobayashi M, Hosokawa M. Yuan L, et al. Among authors: kobayashi m. Cancer Immunol Immunother. 1995 Dec;41(6):355-62. doi: 10.1007/BF01526555. Cancer Immunol Immunother. 1995. PMID: 8635193 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12,174 results

Search Page

Filters